Asia Pacific Sleep Disorder Treatment Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2021 –2028 |
 Taille du marché (année de référence) |
USD 251.28 Million |
 Taille du marché (année de prévision) |
USD 435.01 Million |
 TCAC |
% |
| Principaux acteurs du marché |
>Marché du traitement des troubles du sommeil en Asie-Pacifique, par type (insomnie, apnée du sommeil, syndrome des jambes sans repos (SJSR), narcolepsie et autres), traitement (thérapie pharmacologique, thérapie mécanique, dispositifs d'avancement mandibulaire, stimulateur du nerf hypoglosse, chirurgie et autres), voie d'administration (orale, parentérale et autres), type de médicaments (génériques et de marque), type de population (adultes et enfants), utilisateur final (hôpitaux, cliniques spécialisées, soins à domicile, centre chirurgical ambulatoire et autres), canal de distribution (appel d'offres direct, pharmacie hospitalière, pharmacie de détail, pharmacie en ligne et autres), pays (Japon, Chine, Inde, Corée du Sud, Australie, Singapour, Thaïlande, Vietnam, Malaisie, Indonésie, Philippines et reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie jusqu'en 2028
Analyse et perspectives du marché : Marché du traitement des troubles du sommeil en Asie-Pacifique
Le marché du traitement des troubles du sommeil en Asie-Pacifique devrait atteindre 435,01 millions USD d'ici 2028, contre 251,28 millions USD en 2020, avec un TCAC de 7,3 % au cours de la période de prévision de 2021 à 2028. Le marché du traitement des troubles du sommeil en Asie-Pacifique devrait croître en raison de la prévalence accrue de troubles du sommeil comme l'apnée du sommeil, l'insomnie et la narcolepsie à travers le monde.
Les troubles du sommeil sont également connus sous le nom de somnipathie. Il s'agit de divers troubles médicaux qui altèrent négativement le rythme de sommeil d'une personne. Les troubles du sommeil peuvent également être définis comme un groupe de troubles ayant un impact régulier sur le rythme de sommeil d'un individu. Divers facteurs sont responsables de la présence de troubles du sommeil, notamment les changements de style de vie et un stress élevé, entre autres. Les troubles du sommeil ont un impact sur la santé globale d'une personne et affectent son niveau de concentration, ce qui entraîne une fatigue tout au long de la journée.
L’apnée du sommeil, l’insomnie, le somnambulisme, la narcolepsie et le syndrome des jambes sans repos (SJSR) sont quelques-uns des troubles du sommeil les plus courants observés dans le monde. Les changements de mode de vie, l’adoption croissante des gadgets et l’utilisation accrue des médias sociaux font augmenter la prévalence des troubles du sommeil dans diverses régions du monde.
Le rapport sur le marché du traitement des troubles du sommeil fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et local, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché du traitement des troubles du sommeil en Asie-Pacifique
Le marché du traitement des troubles du sommeil est divisé en sept segments notables qui sont basés sur le type, le traitement, la voie d'administration, le type de médicament, le type de population, l'utilisateur final et le canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base du type, le marché du traitement des troubles du sommeil est segmenté en insomnie , apnée du sommeil, syndrome des jambes sans repos (SJSR), narcolepsie et autres. En 2021, le segment de l'insomnie devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique en raison des progrès technologiques visant à développer des options de traitement innovantes pour ce trouble particulier.
- Sur la base du traitement, le marché du traitement des troubles du sommeil est segmenté en thérapie pharmacologique, thérapie mécanique, dispositifs d'avancement mandibulaire, stimulateur du nerf hypoglosse, chirurgie et autres. En 2021, le segment de la thérapie pharmacologique devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique, car de nombreuses classes de médicaments sont disponibles pour le traitement des troubles du sommeil en fonction des symptômes des patients.
- En fonction de la voie d'administration, le marché du traitement des troubles du sommeil est segmenté en voie orale , parentérale et autres. En 2021, le segment oral devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique en raison de la disponibilité accrue de médicaments oraux pour le traitement des troubles du sommeil comme la narcolepsie, le syndrome des jambes sans repos (SJSR) et l'insomnie, entre autres.
- Sur la base du type de médicament, le marché du traitement des troubles du sommeil est segmenté en médicaments de marque et génériques. En 2021, le segment des génériques devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique en raison de la disponibilité accrue de médicaments génériques pour le traitement des troubles du sommeil comme la gabapentine, les comprimés de zolpidem ER et les comprimés d'eszopiclone, CIV, entre autres.
- En fonction du type de population, le marché du traitement des troubles du sommeil est segmenté en enfants et adultes . En 2021, le segment des adultes devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique en raison de l'augmentation de la population gériatrique à travers le monde, qui nécessite des options de traitement plus avancées.
- Sur la base de l'utilisateur final, le marché du traitement des troubles du sommeil est segmenté en hôpitaux , cliniques spécialisées, soins à domicile, centres de chirurgie ambulatoire et autres. En 2021, le segment des hôpitaux devrait dominer le marché du traitement des troubles du sommeil en Asie-Pacifique en raison des capacités financières des hôpitaux à acheter des équipements coûteux utilisés en chirurgie ainsi que de la présence de professionnels qualifiés pour faire fonctionner les appareils mécaniques et les médicaments prescrits.
- On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, direct tender segment is expected to dominate the Asia-Pacific sleep disorder treatment market as most of the drugs are procured through direct tender services.
Sleep Disorder Treatment Market Country Level Analysis
The sleep disorder treatment market is categorized into segments which are based on the country, type, treatment, route of administration, drugs type, population type, end user and distribution channel.
The Asia-Pacific sleep disorder treatment market on the basis of country is segmented into Japan, China, India, South Korea, Australia, Singapore, Thailand, Vietnam, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.
In Asia-Pacific, Japan is expected to dominate because of the technological advancements in order to develop innovative treatment options for the particular disorder.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufactures is Creating New Opportunities for Players in the Sleep Disorder Treatment Market
Sleep disorder treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with sleep disorder treatment market sales, impact of advancement in the sleep disorder treatment market and changes in regulatory scenarios with their support for the sleep disorder treatment market. The data is available for historic period 2011 to 2019.
Competitive Landscape and Sleep Disorder Treatment Market Share Analysis
Sleep disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to sleep disorder treatment market.
Les principaux acteurs couverts par le rapport sur le marché du traitement des troubles du sommeil sont Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Amneal Pharmaceuticals LLC, Taj Pharmaceuticals Limited, Eli Lilly and Company, Alembic Pharmaceuticals Limited, Apotex Inc., Dr. Reddy's Laboratories Ltd., Koninklijke Philips NV, ResMed, SomnoMed, Oventus et BMC Medical Co., entre autres. Les analystes de DBMR comprennent les atouts de la concurrence et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux lancements de produits et accords sont également initiés par des entreprises du monde entier, ce qui accélère également le marché du traitement des troubles du sommeil.
- En novembre 2019, Pfizer, Inc. a annoncé que sa division Upjohn fusionnait avec Mylan NV pour former une nouvelle société appelée Viatris. Cette fusion de la division commerciale de la société avec Mylan NV a permis d'élargir son portefeuille de produits, ce qui a entraîné une demande accrue pour son produit sur le marché.
Ce nouveau produit lancé par la société a augmenté son portefeuille d'estimation des protéines sur le marché. La collaboration, les coentreprises et d'autres stratégies de l'acteur du marché améliorent le marché de l'entreprise sur le marché du traitement des troubles du sommeil, ce qui offre également l'avantage aux organisations d'améliorer leur offre sur le marché du traitement des troubles du sommeil.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
5 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: REGULATIONS
6 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF SLEEPING DISORDERS
7.1.2 RISE IN THE GERIATRIC POPULATION
7.1.3 INCREASE IN MENTAL STRESS DUE TO HECTIC LIFE & UNHEALTHY HABITS
7.1.4 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS
7.1.5 PRESENCE OF POTENTIAL CLINICAL PIPELINE CANDIDATES
7.2 RESTRAINTS
7.2.1 SIDE EFFECTS ASSOCIATED WITH THESE DRUGS
7.2.2 PATENT EXPIRATION OF MAJOR SLEEP DISORDER TREATMENT DRUGS
7.2.3 EMERGENCE OF GENERICS
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE SLEEP AIDS
7.3.2 INCREASING USAGE OF SOCIAL MEDIA AND GROWING ADDICTION OF GADGETS SUCH AS SMARTPHONES AND LAPTOPS
7.3.3 GROWING AWARENESS ABOUT TARGET DISEASE
7.4 CHALLENGES
7.4.1 HIGH COST OF DIAGNOSIS & TREATMENT FOR SLEEPING DISORDER
7.4.2 STRINGENT REGULATORY LANDSCAPE
7.4.3 POTENTIAL ILL-EFFECTS DUE TO DRUG ABUSE
8 IMPACT OF COVID-19 ON ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19
8.5 CONCLUSION
9 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE
9.1 OVERVIEW
9.2 INSOMNIA
9.2.1 INSOMNIA
9.2.2 CHILD INSOMNIA
9.2.3 OTHERS
9.3 SLEEP APNEA
9.3.1 OBSTRUCTIVE SLEEP APNEA
9.3.2 CENTRAL SLEEP APNEA
9.3.3 SNORING
9.3.4 INFANT SLEEP APNEA
9.3.5 OTHERS
9.4 RESTLESS LEGS SYNDROME (RLS)
9.5 NARCOLEPSY
9.5.1 TYPE 1
9.5.2 TYPE 2
10 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TREATMENT
10.1 OVERVIEW
10.2 PHARMACOLOGICAL THERAPY
10.2.1 CANNABIDIOL
10.2.2 ANTI-PARKINSONIAN DRUGS (DOPAMINE AGONISTS)
10.2.3 BENZODIAZEPINES
10.2.4 NON-BENZODIAZEPINE
10.2.5 MELATONIN RECEPTOR STIMULATOR
10.2.6 STIMULANTS
10.2.7 SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) OR SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS)
10.2.8 TRICYCLIC ANTIDEPRESSANTS
10.2.9 SODIUM OXYBATE (XYREM)
10.2.10 OTHERS
10.3 MECHANICAL THERAPY
10.3.1 CPAP (CONTINUOUS POSITIVE AIRWAY PRESSURE)
10.3.2 BI-LEVEL PAP
10.3.3 AUTO CPAP OR AUTO BI-LEVEL PAP
10.3.4 ADAPTIVE SERVO-VENTILATION (ASV)
10.4 MANDIBULAR ADVANCEMENT DEVICES
10.5 HYPOGLOSSAL NERVE STIMULATOR
10.6 SURGERY
10.6.1 SOMNOPLASTY
10.6.2 TONSILLECTOMY
10.6.3 NASAL SURGERY
10.6.4 OTHERS
10.7 OTHERS
11 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
11.1 OVERVIEW
11.2 ORAL
11.2.1 TABLET
11.2.2 PILLS
11.2.3 OTHERS
11.3 PARENTERAL
11.4 OTHERS
12 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE
12.1 OVERVIEW
12.2 GENERICS
12.3 BRANDED
12.3.1 XYREM
12.3.2 EFFEXOR XR
12.3.3 AMBIEN
12.3.4 PRISTIQ
12.3.5 ZENZEDI
12.3.6 VYVANSE
12.3.7 OTHERS
13 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE
13.1 OVERVIEW
13.2 ADULT
13.3 CHILDREN
14 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 SPECIALTY CLINICS
14.4 HOME HEALTHCARE
14.5 AMBULATORY SURGICAL CENTER
14.6 OTHERS
15 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 HOSPITAL PHARMACY
15.4 RETAIL PHARMACY
15.5 ONLINE PHARMACY
15.6 OTHERS
16 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY GEOGRAPHY
16.1 ASIA-PACIFIC
16.1.1 JAPAN
16.1.2 CHINA
16.1.3 SOUTH KOREA
16.1.4 INDIA
16.1.5 AUSTRALIA
16.1.6 SINGAPORE
16.1.7 THAILAND
16.1.8 MALAYSIA
16.1.9 INDONESIA
16.1.10 PHILIPPINES
16.1.11 VIETNAM
16.1.12 REST OF ASIA-PACIFIC
17 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 JAZZ PHARMACEUTICALS, INC.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 PFIZER INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENT
19.3 ELI LILLY AND COMPANY
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 VIATRIS INC.
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 RESMED
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENTS
19.6 MALLINCKRODT
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENT
19.7 KONINKLIJKE PHILIPS N.V.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 ALEMBIC PHARMACEUTICALS LIMITED
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENT
19.9 AMNEAL PHARMACEUTICALS LLC
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 APOTEX INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 ARBOR PHARMACEUTICALS
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENTS
19.12 AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENTS
19.13 BMC MEDICAL CO.
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 DEVILBISS HEALTHCARE LLC
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 DR. REDDY’S LABORATORIES LTD.
19.15.1 COMPANY SNAPSHOT
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENT
19.16 HIKMA PHARMACEUTICALS PLC
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENTS
19.17 LUPIN PHARMACEUTICALS, INC. (A SUBSIDIARY OF LUPIN)
19.17.1 COMPANY SNAPSHOT
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENTS
19.18 OVENTUS
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENTS
19.19 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
19.19.1 COMPANY SNAPSHOT
19.19.2 REVENUE ANALYSIS
19.19.3 PRODUCT PORTFOLIO
19.19.4 RECENT DEVELOPMENTS
19.2 SOMNOMED
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENTS
19.21 TAJ PHARMACEUTICALS LIMITED
19.21.1 COMPANY SNAPSHOT
19.21.2 PRODUCT PORTFOLIO
19.21.3 RECENT DEVELOPMENT
19.22 TARO PHARMACEUTICAL INDUSTRIES LTD.
19.22.1 COMPANY SNAPSHOT
19.22.2 REVENUE ANALYSIS
19.22.3 PRODUCT PORTFOLIO
19.22.4 RECENT DEVELOPMENT
19.23 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
19.23.1 COMPANY SNAPSHOT
19.23.2 REVENUE ANALYSIS
19.23.3 PRODUCT PORTFOLIO
19.23.4 RECENT DEVELOPMENTS
20 QUESTIONNAIRE
21 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS
TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT
TABLE 3 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 4 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 5 ASIA-PACIFIC INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 6 ASIA-PACIFIC SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 7 ASIA-PACIFIC SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 8 ASIA-PACIFIC RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 9 ASIA-PACIFIC NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 10 ASIA-PACIFIC NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 11 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)
TABLE 12 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 13 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 14 ASIA-PACIFIC MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 15 ASIA-PACIFIC MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 16 ASIA-PACIFIC MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 17 ASIA-PACIFIC HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 18 ASIA-PACIFIC SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 19 ASIA-PACIFIC SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 20 ASIA-PACIFIC OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 21 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 22 ASIA-PACIFIC ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 23 ASIA-PACIFIC ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 24 ASIA-PACIFIC PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 25 ASIA-PACIFIC OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 26 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 27 ASIA-PACIFIC GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 28 ASIA-PACIFIC BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 29 ASIA-PACIFIC BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 30 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)
TABLE 31 ASIA-PACIFIC ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 32 ASIA-PACIFIC CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 33 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)
TABLE 34 ASIA-PACIFIC HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 35 ASIA-PACIFIC SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 36 ASIA-PACIFIC HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 37 ASIA-PACIFIC AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 38 ASIA-PACIFIC OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 39 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 41 ASIA-PACIFIC HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 42 ASIA-PACIFIC RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 43 ASIA-PACIFIC ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 44 ASIA-PACIFIC HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 45 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 52 ASIA-PACIFIC MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 53 ASIA-PACIFIC SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 54 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 55 ASIA-PACIFIC ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 56 ASIA-PACIFIC PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 57 ASIA-PACIFIC BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 58 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 59 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 60 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 61 JAPAN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 JAPAN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 JAPAN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 64 JAPAN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 65 JAPAN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 66 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 67 JAPAN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 68 JAPAN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 69 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 70 JAPAN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 71 JAPAN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 72 JAPAN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 73 JAPAN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 74 JAPAN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 75 JAPAN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 76 CHINA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 CHINA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 CHINA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 79 CHINA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 80 CHINA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 81 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 82 CHINA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 83 CHINA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 84 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 85 CHINA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 86 CHINA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 87 CHINA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 88 CHINA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 89 CHINA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 90 CHINA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 91 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 SOUTH KOREA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 93 SOUTH KOREA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 94 SOUTH KOREA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 95 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 96 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 97 SOUTH KOREA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 98 SOUTH KOREA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 99 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 100 SOUTH KOREA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 101 SOUTH KOREA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 102 SOUTH KOREA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 103 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 104 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 105 SOUTH KOREA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 106 INDIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 INDIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 INDIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 109 INDIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 110 INDIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 111 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 112 INDIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 113 INDIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 114 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 115 INDIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 116 INDIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 117 INDIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 118 INDIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 119 INDIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 120 INDIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 121 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 AUSTRALIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 123 AUSTRALIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 124 AUSTRALIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 125 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 126 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 127 AUSTRALIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 128 AUSTRALIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 129 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 130 AUSTRALIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 131 AUSTRALIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 132 AUSTRALIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 133 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 134 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 135 AUSTRALIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 136 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 SINGAPORE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 SINGAPORE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 139 SINGAPORE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 140 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 141 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 142 SINGAPORE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 143 SINGAPORE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 144 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 145 SINGAPORE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 146 SINGAPORE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 147 SINGAPORE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 148 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 149 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 150 SINGAPORE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 151 THAILAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 152 THAILAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 153 THAILAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 154 THAILAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 155 THAILAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 156 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 157 THAILAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 158 THAILAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 159 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 160 THAILAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 161 THAILAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 162 THAILAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 163 THAILAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 164 THAILAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 165 THAILAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 166 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 167 MALAYSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 MALAYSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 169 MALAYSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 170 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 171 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 172 MALAYSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 173 MALAYSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 174 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 175 MALAYSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 176 MALAYSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 177 MALAYSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 178 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 179 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 180 MALAYSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 181 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 182 INDONESIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 183 INDONESIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 184 INDONESIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 185 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 186 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 187 INDONESIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 188 INDONESIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 189 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 190 INDONESIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 191 INDONESIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 192 INDONESIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 193 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 194 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 195 INDONESIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 196 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 197 PHILIPPINES INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 198 PHILIPPINES SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 199 PHILIPPINES NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 200 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 201 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 202 PHILIPPINES MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 203 PHILIPPINES SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 204 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 205 PHILIPPINES ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 206 PHILIPPINES PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 207 PHILIPPINES BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 208 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 209 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 210 PHILIPPINES SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 211 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 212 VIETNAM INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 213 VIETNAM SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 214 VIETNAM NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 215 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 216 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 217 VIETNAM MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 218 VIETNAM SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 219 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 220 VIETNAM ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 221 VIETNAM PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 222 VIETNAM BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 223 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 224 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 225 VIETNAM SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 226 REST OF ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET
FIGURE 14 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)
FIGURE 15 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)
FIGURE 16 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020
FIGURE 17 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 18 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)
FIGURE 19 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020
FIGURE 21 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)
FIGURE 22 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)
FIGURE 23 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 24 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 25 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)
FIGURE 26 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)
FIGURE 27 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 28 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020
FIGURE 29 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)
FIGURE 30 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)
FIGURE 31 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 32 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020
FIGURE 33 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)
FIGURE 34 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)
FIGURE 35 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 36 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020
FIGURE 37 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 38 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)
FIGURE 39 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 42 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 43 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)
FIGURE 45 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)
FIGURE 46 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)
FIGURE 49 ASIA-PACIFIC SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
